Patients with heroin dependence and the TT genotype may have decreased dose requirements of methadone when receiving methadone maintenance therapy (MMT) as compared to patients with the CC or CT genotypes. Other genetic and clinical factors may also affect a patient's dose requirements when receiving MMT.